The number of newly developed therapies grows every year, and cancer care is becoming more and more personalized. Most cancer treatments work by targeting certain tumor cell proteins or the interplay between tumor and immune cells. This means clinicians need to know which proteins are present on which types of cells and where they are located. This information is exactly what we provide with our spatial single-cell proteomic approach.
With our highly multiplex imaging technology, we can detect and visualize up to 50 proteins from just a single tumor section. Analyzing these high-resolution images with our automated computational workflows lets us quantify an exceptional amount of information from so little tumor material.